Sean McClain, Absci’s Founder and CEO, said, “AMD high-performance compute will enable us to further the development of next-generation antibody therapeutics, and we are excited about the ...
Absci's Founder & CEO, Sean McClain, highlighted the importance of the partnership during his presentation at the 43rd Annual J.P. Morgan Healthcare Conference. He emphasized that working with AMD ...
Absci's CEO Sean McClain will address the partnership at the upcoming J.P. Morgan Healthcare Conference on January 15, 2025. Both companies are excited about the potential to revolutionize the ...
Absci Founder & CEO Sean McClain will discuss the strategic partnership at the 43rd Annual J.P.Morgan Healthcare Conference on Wednesday January 15th at 4:30pm PT. Absci and AMD will showcase the ...